BioPharma Dive 2025-12-08 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 2025-12-08 Dyne to seek Duchenne drug approval; Kymera, Wave and Structure shares soar
BioPharma Dive 2025-12-05 Hemophilia gene therapies are struggling on the market, even as innovation soars
BioPharma Dive 2025-12-03 After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis